BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37606876)

  • 1. Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.
    Zhang Y; Sheng H; Fu Y; Chen L
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37606876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway.
    Cao J; Zhang H; Wei X; Zhou H
    Chem Biol Drug Des; 2024 Jan; 103(1):e14445. PubMed ID: 38230786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFAP2A activates HMGA1 to promote glycolysis and lung adenocarcinoma progression.
    Zhao J; Lan G
    Pathol Res Pract; 2023 Sep; 249():154759. PubMed ID: 37586214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
    Liu G; Liu X; Zeng W; Zhou W
    Pharmacology; 2024 Apr; ():1-14. PubMed ID: 38643755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
    Zhang Z; Qi D; Liu X; Kang P
    Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.
    Li Z; Zhu T; Yao F; Shen X; Xu M; Fu L; Wu Y; Ding J; Zhang J; Zhao J; Dong L; Wang X; Yu G
    J Bioenerg Biomembr; 2024 Apr; 56(2):181-191. PubMed ID: 38411863
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xie K; Feng J; Fan D; Wang S; Luo J; Ren Z; Zheng C; Diao Y; De Mello RA; Tavolari S; Brandi G; Roden AC; Ren B; Shen Y; Xu L
    Transl Lung Cancer Res; 2022 Jul; 11(7):1405-1419. PubMed ID: 35958341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
    Chen W; Li X; Du B; Cui Y; Ma Y; Li Y
    Cancer Med; 2023 Feb; 12(4):4421-4433. PubMed ID: 35924724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIMAP7 inhibits epithelial-mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway.
    Cui L; Shen Y; Duan S; Ding Q; Wang Y; Yang W; Chen Y
    Thorac Cancer; 2024 Feb; 15(4):286-298. PubMed ID: 38151913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.
    Wang M; He T; Meng D; Lv W; Ye J; Cheng L; Hu J
    J Proteome Res; 2023 Dec; 22(12):3854-3865. PubMed ID: 37955350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
    Hu Y; Mu H; Deng Z
    Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
    Wang N; Wang J
    Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXA1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
    Wei J; Yu H; Liu T; Wang Z; Lang C; Pan Y
    Thorac Cancer; 2023 Jul; 14(21):2026-2037. PubMed ID: 37277890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA6 Suppresses Lung Adenocarcinoma Progression by Activating CFTR to Modulate Arachidonic Acid Metabolism.
    Lin Y; Chen Y; Zhang Y; Weng J; Shen R; Zhang W; Lin Y
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38299406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
    Ma Y; Ma X; Du B; Li X; Li Y
    J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.
    Xing Y; Luo P; Hu R; Wang D; Zhou G; Jiang J
    Cancer Manag Res; 2020; 12():13195-13206. PubMed ID: 33380827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma.
    Dong L; Feng C; Cheng W; Huang A; Ying K
    Acta Biochim Biophys Sin (Shanghai); 2024 May; ():. PubMed ID: 38798241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.